Documento de consenso de la Sociedad Española de Reumatología para el uso de opioides en el tratamiento del dolor reumático

Badley, 1995, The provision of reumatological services Carmona, 2001, The burden of musculoskeletal diseases in the general population of Spain: results from a national survey, Ann Rheum Dis, 60, 1040, 10.1136/ard.60.11.1040 Bellamy, 1996, Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis, Arthritis Rheum, 39, 357, 10.1002/art.1780390302 Nurmikko, 1998, Control of chronic pain, BMJ, 317, 1438, 10.1136/bmj.317.7170.1438 Conno, 2005, Opioid purchases and expenditure in nine western European countries:“Are we killing off morphine?”, Palliative Medicine, 19, 179, 10.1191/0269216305pm1002oa Woolf, 2004, Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries, Ann Rheum Dis, 63, 342, 10.1136/ard.2003.010223 Kalso, 2003, Recommendations for using opioids in chronic non-cancer pain, Eur J Pain, 7, 381, 10.1016/S1090-3801(02)00143-X American Academy of Pain Medicine. Long-term controlled substances therapy for chronic pain. Sample agreement, 2001. Disponible en: http://www.painmed.org/productpub/statements/sample.html Recommendations for the appropriateuse of opioids for persistent non-cancer pain. The England Pain Society; 2004. Jovey, 2003, Canadian Pain Society. Use of opioid analgesics for the treatment of chronic noncancer pain –a consensus statement and guidelines from the Canadian Pain Society, 2002, Pain Res Manag, 8, A3, 10.1155/2003/436716 Jensen, 2001 Ferraz, 1990, Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis, J Rheumatol, 17, 1022 Turk, 1999, Assessment of patients reporting of pain: an integrated perspective, Lancet, 353, 1784, 10.1016/S0140-6736(99)01309-4 Turk, 2002, Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain, Clin J Pain, 18, 355, 10.1097/00002508-200211000-00003 Guy, 1976 Shen, 2005, Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis, Arthritis Rheum, 52, 1402, 10.1002/art.21141 Malonne, 2004, Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study, Clin Ther, 26, 1774, 10.1016/j.clinthera.2004.11.005 Caldwell, 2002, Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial, J Pain Symptom Manage, 23, 278, 10.1016/S0885-3924(02)00383-4 Griessinger, 2003, The role of opioid analgesics in rheumatoid disease in the elderly population, Drugs Aging, 20, 571, 10.2165/00002512-200320080-00003 Allan, 2001, Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain, BMJ, 322, 1154, 10.1136/bmj.322.7295.1154 Sittl, 2003, Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial, Clin Ther, 25, 150, 10.1016/S0149-2918(03)90019-1 Peloso, 2004, Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial, J Rheumatol, 31, 2454 Hale, 1999, Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain, Clin J Pain, 15, 179, 10.1097/00002508-199909000-00004 Milligan, 2001, Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain, J Pain, 2, 197, 10.1054/jpai.2001.25352 Mystakidou, 2003, Long-term management of noncancer pain with transdermal therapeutic system-fentanyl, J Pain, 4, 298, 10.1016/S1526-5900(03)00632-1 Sorge, 1997, Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain, Clin Drug Invest, 14, 157, 10.2165/00044011-199714030-00001 Rosenthal, 2004, Tramadol/ acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population, J Am Geriatr Soc, 52, 374, 10.1111/j.1532-5415.2004.52108.x Sorge, 1997, Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain, Clin Drug Invest, 14, 157, 10.2165/00044011-199714030-00001 Roth, 2000, Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation, Arch Intern Med, 160, 853, 10.1001/archinte.160.6.853 Portenoy, 1996, Opioid therapy for chronic nonmalignant pain: a review of the critical issues, J Pain Symptom Manage, 11, 203, 10.1016/0885-3924(95)00187-5 Ballantyne, 2003, Opioid therapy for chronic pain, N Eng J Med, 349, 1943, 10.1056/NEJMra025411 McQuay, 1999, Opioids in pain management, Lancet, 353, 2229, 10.1016/S0140-6736(99)03528-X The use of opioids for the treatment of chronic pain: a consensus statement from American Academy of Pain Medicine and American Pain Society. Disponible en: http://www.ampainsoc.org/advocacy/opioids.htm